[1]CurrentPatentAssignee:MERCK&COINC-WO2004/814,2003,A1Locationinpatent:Page53
[1]CurrentPatentAssignee:JOHNSON&JOHNSONINC-US2011/105520,2011,A1Locationinpatent:Page/Pagecolumn33-34
913836-01-8
22098-10-8 | Ethyl (5-bromothien-2-yl)glyoxylate | AA00706S | MFCD00085056
134362-79-1 | N-[(1R)-2-[[(1S,2R,3S)-1-(CYCLOHEXYLMETHYL)-3-CYCLOPROPYL-2,3-DIHYDROXYPROPYL]AMINO]-2-OXO-1-(THIAZOL-4-YLMETHYL)ETHYL]-1H-BENZO[D]IMIDAZOLE-2-CARBOXAMIDE | AA0070MR | MFCD07363878
136-16-3 | Thiazolium,3-[(3,4-dihydro-2-methyl-4-oxo-5-pyrimidinyl)methyl]-5-(2-hydroxyethyl)-4-methyl- | AA007124 | MFCD00050656
4720-68-7 | 6-Hydroxybenzo[d][1,3]dioxole-5-carbaldehyde | AA0071H2 | MFCD09864084
46698-36-6 | (4-Chlorophenyl)(3-fluorophenyl)methanone | AA0071YK | MFCD09801597
1335-32-6 | Lead subacetate | AA0072EC | MFCD00013041
438554-06-4 | 3-Nitro-4-(propylamino)benzonitrile | AA0072TJ | MFCD12188574
41052-26-0 | 2-Bromo-5-nitrobenzamide | AA0073AC | MFCD01320498
1962-83-0 | Norleucine, 6-oxo- | AA0073SW | MFCD06799471
3937-30-2 | Silane,dimethyl-2-propen-1-yl- | AA0074A9 | MFCD00053697
